Event Type
Disclosure
Voluntary
Variant
8-K
, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or into any fi
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 NewAmsterdam Pharma Company N.V. Corporate Presentation, dated March 2, 2026. 104